Intravacc, a contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, and the German Center for Neurogenerative Diseases (DZNE), have been awarded a funding of €2.5 million from the European Union (EIC Transition Grant) to further develop a prototype amyotrophic lateral sclerosis (ALS) vaccine, including process development, scale-up and toxicology study. The project aims to develop the vaccine candidate identified at DZNE to the point where it can be cl...